elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26751659-0A4D23EF-08ED-4642-B9E8-991F2B63F621
Q26751659-0A4D23EF-08ED-4642-B9E8-991F2B63F621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751659-0A4D23EF-08ED-4642-B9E8-991F2B63F621
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
P2860
Q26751659-0A4D23EF-08ED-4642-B9E8-991F2B63F621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751659-0A4D23EF-08ED-4642-B9E8-991F2B63F621
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cb4b3b1ed637623b08c1518213d67b8277ecec0
P2860
PD-L2 is a second ligand for PD-1 and inhibits T cell activation